Metaplastic breast carcinoma must be distinguished to the commonly noticed superior-quality metaplastic carcinoma and the rare kinds of metaplastic carcinoma with uncertain malignant prospective (fibromatous-like and adenosquamous carcinoma). Usually, metaplastic breast carcinomas are malignancies with triple-destructive immune phenotype, but their